# BetterLife Pharma Inc. (BETRF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BETRF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2027 | $ 0 | $ -609.1K | $ -239.2K | $ 617.3K | $ -9.73M |
| 2026 | $ 0 | $ -1.50M | $ -626.1K | $ 906.4K | $ -9.80M |
| 2025 | $ 0 | $ -3.52M | $ -2.02M | $ 1.30M | $ -10.68M |
| 2024 | $ 0 | $ -2.94M | $ -2.52M | $ 245.2K | $ -10.81M |
| 2023 | $ 0 | $ -9.35M | $ -1.56M | $ 1.19M | $ -10.73M |
| 2022 | $ 0 | $ -13.05M | $ -12.02M | $ 1.40M | $ -3.88M |
| 2021 | $ 0 | $ -41.46M | $ -8.29M | $ 500.0K | $ -4.61M |
| 2020 | $ 0 | $ -23.42M | $ -9.55M | $ 4.70M | $ 2.66M |
| 2019 | $ 0 | $ -10.06M | $ -5.99M | $ 3.50M | $ 3.51M |
| 2018 | $ 0 | $ -216.7K | $ -600.9K | $ 248.2K | $ -56.0K |
| 2017 | $ 0 | $ -9.91M | $ -621.7K | $ 360.4K | $ -1.93M |
| 2016 | $ 0 | $ -15.48M | $ -293.1K | $ 0 | $ -459.8K |
| 2015 | $ 0 | $ -1.30M | $ -68.4K | $ 0 | $ -69.4K |
| 2014 | $ 0 | $ -994.6K | $ -36.0K | $ 342.2K | $ -750.5K |
| 2013 | $ 0 | $ 457.1K | $ -42.3K | $ 219.5K | $ -674.6K |
| 2012 | $ 0 | $ 1.92M | $ -184.1K | $ 99.8K | $ -1.02M |
| 2011 | $ 0 | $ -4.13M | $ -147.2K | $ 10.7K | $ -2.95M |
| 2010 | $ 0 | $ -167.9K | $ -50.6K | $ 0 | $ 4.2K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.06 |
| Liabilities / Eq | -0.69 |
| Current Ratio | 0.04 |

## Other views

- [Metrics](https://sponda.capital/en/BETRF.md)
- [Charts](https://sponda.capital/en/BETRF/charts.md)
- [Compare](https://sponda.capital/en/BETRF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-28.